Public Meeting on Patient-Focused Drug Development for Huntington’s and Parkinson’s Diseases

On September 22, 2015, FDA held a public meeting on Patient-Focused Drug Development for Huntington’s disease and Parkinson’s disease. To obtain:

  • Patients’ perspectives on the impact of Huntington’s disease and Parkinson’s disease on daily life
  • Patient views on treatment approaches.

http://www.fda.gov/drugs/newsevents/ucm451807.htm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s